Eliquis Sprinkle

Generic name: apixaban

Used for: Preventing stroke in atrial fibrillation (AFib) · Blood clots in the legs or lungs (DVT, PE) · Preventing blood clots after hip or knee replacement · 2 more

How do you pay?

How to pay the least

Ask for the cash price

Eliquis Sprinkle

We didn’t find one.

  1. Ask your pharmacy for Eliquis Sprinkle’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameEliquis Sprinkle
Authorized genericapixaban
Regular genericapixaban
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Eliquis Sprinkle?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Eliquis Sprinkle’s maker. Ask the pharmacy for Eliquis Sprinkle’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Eliquis Sprinkle itself, from the same company, sold without the brand name, and usually for less. For now Eliquis Sprinkle is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Eliquis Sprinkle’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation

ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.

Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery

ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in adult patients who have undergone hip or knee replacement surgery.

Treatment of Deep Vein Thrombosis

ELIQUIS is indicated for the treatment of adults with deep vein thrombosis (DVT).

Treatment of Pulmonary Embolism

ELIQUIS is indicated for the treatment of adults with pulmonary embolism (PE).

Reduction in the Risk of Recurrence of Deep Vein Thrombosis and Pulmonary Embolism

ELIQUIS is indicated to reduce the risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients following initial therapy.

Treatment of Venous Thromboembolism and Reduction in the Risk of Recurrent Venous Thromboembolism in Pediatric Patients

ELIQUIS is indicated for the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in pediatric patients from birth and older after at least 5 days of initial anticoagulant treatment.

Source: the FDA label for Eliquis Sprinkle (Bristol), June 24, 2026. Full label from the FDA (PDF) 

Good to know

Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/eliquis-sprinkle/